- Home
- Results news
- Roselabs Finance
- Q2 FY27 results
Roselabs Finance Q2 FY27 results: net loss widens to ₹0.06 crore
Roselabs Finance Ltd reported a standalone net loss of ₹0.06 crore for Q2 FY27, with revenue of ₹0 crore and total expenses of ₹0.06 crore. The loss was unchanged from Q2 FY26 but widened from a net loss of ₹0.05 crore in Q1 FY27, while basic EPS was ₹0.06. The board approved the unaudited results on 22 October 2026, and the review report carried an unmodified conclusion.
Key points
- Q2 FY27 revenue was ₹0 crore, unchanged from Q2 FY26 and Q1 FY27.
- Total expenses were ₹0.06 crore in Q2 FY27, up ₹0.01 crore from Q1 FY27.
- Roselabs Finance reported a net loss of ₹0.06 crore in Q2 FY27, against a net loss of ₹0.05 crore in Q1 FY27.
- Basic EPS was ₹0.06 in Q2 FY27, compared with ₹0.05 in Q1 FY27 and ₹0.06 in Q2 FY26.
- The stock closed unchanged at 0.0% on the reaction day, against a 1.1% fall in the industry median.
How did Roselabs Finance perform in Q2 FY27?
Roselabs Finance reported standalone revenue of ₹0 crore for Q2 FY27, the July–September 2026 quarter, unchanged from Q2 FY26 and from Q1 FY27. Total expenses were ₹0.06 crore and EBITDA was a loss of ₹0.06 crore, while profit before tax and net profit were each a loss of ₹0.06 crore. Basic EPS was ₹0.06 for the quarter.
The quarterly loss was unchanged from Q2 FY26, when revenue was ₹0 crore, total expenses were ₹0.06 crore and the net loss was ₹0.06 crore. Against the previous quarter, Q1 FY27, the net loss widened by ₹0.01 crore from ₹0.05 crore, and basic EPS moved from ₹0.05 to ₹0.06. The results shown are on a standalone basis; no consolidated figures were given.
An EBITDA margin was not reported for the quarter, and there was no exceptional item in Q2 FY27, Q1 FY27 or Q2 FY26. The board approved the unaudited financial results for the quarter and half year ended 30 September 2026 on 22 October 2026, and the limited review report issued by Walker Chandiok & Co LLP carried an unmodified conclusion.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 0 | 0 | 0 | ||
| Other income | 0 | 0 | 0 | ||
| Total expenses | 0.06 | 0.05 | 0.06 | +0.0% | +20.0% |
| EBITDA | −0.06 | −0.05 | −0.06 | ||
| Profit before tax | −0.06 | −0.05 | −0.06 | ||
| Tax | 0 | 0 | 0 | ||
| Net profit | −0.06 | −0.05 | −0.06 | ||
| EPS (₹) | −0.06 | −0.05 | −0.06 |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Roselabs Finance's costs and profit?
Total expenses for Q2 FY27 were ₹0.06 crore, unchanged from Q2 FY26 and up ₹0.01 crore from Q1 FY27. Employee benefit expense was ₹0.01 crore, unchanged from the year-ago quarter but down ₹0.01 crore from Q1 FY27, when it was ₹0.02 crore. Other expenses were ₹0.05 crore, unchanged from Q2 FY26 and up ₹0.02 crore from Q1 FY27, when they were ₹0.03 crore.
Other income was ₹0 crore in Q2 FY27, unchanged from Q2 FY26 and Q1 FY27, and there was no exceptional item in any of the three quarters. Tax expense was ₹0 crore in Q2 FY27, unchanged from the year-ago quarter and the previous quarter. The filing does not state a reason for the increase in other expenses from the previous quarter.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 0 | 0 | 0 | |
| Employee cost | 0.01 | 0.01 | 0 | +0.0% |
| Finance costs | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | |
| Other expenses | 0.05 | 0.05 | 0 | +0.0% |
| Total expenses | 0.06 | 0.06 | 0 | +0.0% |
| Other income | 0 | 0 | 0 | |
| Tax | 0 | 0 | 0 |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
For the first half of FY27, revenue and total income were ₹0 crore, unchanged from H1 FY26. Loss before tax was ₹0.12 crore in H1 FY27 against a loss of ₹0.11 crore in H1 FY26, a difference of ₹0.01 crore.
The net loss for H1 FY27 was ₹0.12 crore, compared with a net loss of ₹0.11 crore in H1 FY26, a difference of ₹0.01 crore. EPS was ₹0.12 in the first half of FY27 against ₹0.11 in H1 FY26, also a difference of ₹0.01 crore.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 0 | 0 | |
| Profit before tax | −0.12 | −0.11 | |
| Net profit | −0.12 | −0.11 | |
| EPS (₹) | −0.12 | −0.11 |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
Total assets were ₹0.04 crore as on 30 September 2026, down from ₹0.06 crore as on 31 March 2026. Total equity was negative ₹5.15 crore against negative ₹5.03 crore at the previous balance sheet date, while borrowings were ₹5.15 crore against ₹5.07 crore. Cash fell to ₹0.02 crore from ₹0.05 crore, and trade payables were ₹0.02 crore at both dates.
For H1 FY27, operating cash flow was negative ₹0.12 crore, unchanged from negative ₹0.12 crore in H1 FY26. Financing cash flow was ₹0.08 crore against ₹0.01 crore a year earlier, investing cash flow was ₹0 crore in both periods, and capital expenditure was ₹0 crore in both periods.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 0.04 | 0.06 |
| Total equity | −5.15 | −5.03 |
| Borrowings | 5.15 | 5.07 |
| Cash and equivalents | 0.02 | 0.05 |
| Inventories | 0 | 0 |
| Trade receivables | 0 | 0 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | −0.12 | −0.12 |
| Cash from investing | 0 | 0 |
| Cash from financing | 0.08 | 0.01 |
| Capital expenditure | 0 | 0 |
Source: Company's results filing (XBRL).
How has Roselabs Finance done over the last 8 quarters?
Revenue over the last eight quarters was intermittent, with ₹0 crore recorded in most quarters and higher readings of ₹0.71 crore in Q4 FY25 and ₹1.21 crore in Q3 FY26. The highest revenue in the series was in Q3 FY26, while the current quarter and the previous three quarters each reported ₹0 crore.
Net loss narrowed from ₹0.11 crore in Q3 FY25 to ₹0.05 crore in Q4 FY25, then moved to ₹0.05 crore in Q1 FY26 and ₹0.06 crore in Q2 FY26. It was lower at ₹0.04 crore in Q3 FY26 and higher at ₹0.16 crore in Q4 FY26, before easing to ₹0.05 crore in Q1 FY27 and widening to ₹0.06 crore in Q2 FY27. EBITDA margin was reported only in the two quarters with revenue, at -6.4% in Q4 FY25 and -3.0% in Q3 FY26.
How did Roselabs Finance shares react?
| After the filing | Stock | Other Financial Services median |
|---|---|---|
| Reaction day | +0.0% | −1.1% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
| Results filed on | Stock on the reaction day |
|---|---|
| 28 July 2026 | +4.1% |
| 16 April 2026 | +1.9% |
| 20 January 2026 | +3.1% |
| 18 July 2025 | +5.0% |
| 18 April 2025 | +0.0% |
| 18 October 2024 | +0.0% |
| 18 July 2024 | −4.8% |
| 19 April 2024 | +0.7% |
Source: MarketPing price-reaction measurement.
How did other Other Financial Services companies do?
Sixteen Other Financial Services companies were compared for revenue growth, with a median revenue growth of -13.7%. The number of peers growing slower than Roselabs Finance and the number growing faster were not provided. Thirteen of the 27 peers compared on profit reported higher profit, according to the peer data as of 4 November 2026.
| Roselabs Finance revenue growth (YoY) | not comparable |
|---|---|
| Median of 16 other Other Financial Services companies | −13.7% |
| Companies whose net profit rose | 13 of 27 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Roselabs Finance's revenue in Q2 FY27?
Revenue from operations was ₹0 crore, against ₹0 crore in Q2 FY26 (standalone).
Did Roselabs Finance make a profit in Q2 FY27?
No. It reported a net loss of ₹0.06 crore, against a net loss of ₹0.06 crore in Q2 FY26.
What was Roselabs Finance's EPS in Q2 FY27?
Basic loss per share was ₹0.06, against a loss of ₹0.06 in Q2 FY26.
How did Roselabs Finance shares react to the Q2 FY27 results?
On the reaction day the stock moved +0.0% from the previous close; the median Other Financial Services stock moved −1.1%.
When did Roselabs Finance announce its Q2 FY27 results?
On 22 October 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Unaudited Financial Results Alongwith Limited Review Report Of The Company For The Quarter And Half Year Ended September 30, 2026 (BSE, 14 October 2026) · PDF
- Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of The Un-Audited Financial Results Alongwith Limited Review Report Of The Company For The Quarter And Half Year Ended September 30, 2026 (BSE, 22 October 2026) · PDF
- Un-Audited Financial Results Alongwith Limited Review Report Of The Company For The Quarter And Half Year Ended September 30, 2026 (BSE, 22 October 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.